about
Glucose-insulin-potassium infusion in sepsis and septic shock: no hard evidence yetIs insulin an endogenous cardioprotector?Insulin and the critically illThe significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.Relationship between hyperglycemia and infection in critically ill patients.Donor care before pancreatic tissue transplantation.Nitric oxide activates intradomain disulfide bond formation in the kinase loop of Akt1/PKBα after burn injury.Effect of pertussis toxin pretreated centrally on blood glucose level induced by stress.Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage.SILAM for quantitative proteomics of liver Akt1/PKBα after burn injury.Current state of glycemic control in critically ill subjects in a general intensive care unit.Burn injury-induced IRS-1 degradation in mouse skeletal muscle.Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction.Insulin treatment improves the systemic inflammatory reaction to severe trauma.Outcome of Critically ill Patients Undergoing Mandatory Insulin Therapy Compared to Usual Care Insulin Therapy: Protocol for a Pilot Randomized Controlled Trial.Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma.Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration?
P2860
Q24794542-C82504F1-290B-42C4-B261-DB3DBB37CD21Q24797044-6C611A25-A693-494A-85E2-1D24B0A37FFBQ24798618-D4B7C55B-B6FA-4A55-A084-C8A1CE2350CBQ24812411-4E2E4068-DFA9-4D07-808E-B52F76FEAD3BQ36188318-0F233458-12F8-4C5A-94BB-03F56D8E0BABQ36192387-B1BEFB17-1896-482B-9421-7E58E242194BQ36684580-BAEA1EE6-3539-4C66-B62B-83BA05B81D64Q37239767-5FFF41E6-D2C9-4646-8928-4B6B77BE0BA3Q37250479-F683E1F7-1549-4B96-B0F8-DE3A00A43A2DQ37694687-E00A5F85-FFCC-4BBE-A382-5D73EB2526E3Q40425736-EFAEA99D-11AC-4638-86C7-97B0B7476E17Q41893791-9D63BEAF-A6BF-47E6-A497-5956BFBD4ABFQ42339422-5838EDB9-7D7A-44E6-ABF8-9650CEA2EAB2Q44801500-136F8E9C-E979-4F2A-A126-6C90C2731AE2Q52665851-B6CDDE7B-1B09-4A9A-B0F3-2423261681C5Q54708723-A70F828F-24A9-4F4D-95DE-10F76EE6B292Q55604491-DA645FCD-7D1B-4374-910F-6740CB6E3335
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin: a wonder drug in the critically ill?
@ast
Insulin: a wonder drug in the critically ill?
@en
Insulin: a wonder drug in the critically ill?
@nl
type
label
Insulin: a wonder drug in the critically ill?
@ast
Insulin: a wonder drug in the critically ill?
@en
Insulin: a wonder drug in the critically ill?
@nl
prefLabel
Insulin: a wonder drug in the critically ill?
@ast
Insulin: a wonder drug in the critically ill?
@en
Insulin: a wonder drug in the critically ill?
@nl
P2093
P2860
P3181
P356
P1433
P1476
Insulin: a wonder drug in the critically ill?
@en
P2093
A B Johan Groeneveld
Albertus Beishuizen
Frans C Visser
P2860
P2888
P3181
P356
10.1186/CC1463
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1011133617